1+ hour, 34+ min ago  (390+ words) Novo Nordisk Announces Significant Price Drops for Popular GLP-1 Medications'Pharmaceutical Executive Novo Nordisk announced price reductions for three of its most popular medications:1 According to the company, the decrease is part of a move to expand access to the popular…...

21+ hour, 39+ min ago  (588+ words) Merck's decision to establish oncology as a standalone business unit reflects a strategic response to blockbuster concentration risk, lifecycle complexity, and intensifying competitive dynamics, as the company prepares for the anticipated loss of exclusivity of Keytruda and repositions organizational design…...

1+ day, 53+ min ago  (567+ words) Gilead Sciences agreed to acquire Arcellx in a deal valued at approximately $7.8 billion in total, deepening its push into cell therapy for multiple myeloma. Despite advances in treatment, multiple myeloma remains incurable, and most patients eventually relapse. With each successive…...

5+ day, 7+ hour ago  (348+ words) The new once-monthly dosing schedule for Rybrevant Faspro in combination with Lazcluze offers a more convenient option and also maintains efficacy and safety comparable to the prior bi-weekly regimen. FDA approved a simplified, once-monthly dosing schedule for Rybrevant Faspro (amivantamab…...

5+ day, 12+ hour ago  (120+ words) In today's Pharmaceutical Executive Daily, the FDA reportedly removes its two-study requirement for new drug approvals, Hims & Hers enters a $1 billion agreement to acquire Eucalyptus, and experts examine how FDA can help ease early-stage clinical trial bottlenecks. Welcome to Pharmaceutical…...

5+ day, 13+ hour ago  (179+ words) Study results showed that patients saw three years of remission while taking the medication. Crohn's patients taking Omvoh saw three-years of remission when taking Omvoh, according to new long-term data released by Eli Lilly.1 The data is the result of…...

6+ day, 5+ hour ago  (338+ words) CSL Limited has licensed global development and commercialization rights for clazakizumab to Eli Lilly and Company outside of ESKD-related cardiovascular risk. CSL Limited entered into an exclusive licensing agreement with Eli Lilly and Company which grants Lilly certain rights to…...

1+ week, 3+ hour ago  (568+ words) HHS Secretary Robert F. Kennedy Jr. reorganized senior leadership at the department to streamline management and advance the administration's health policy priorities. Amongst shakeups in leadership positions ahead of midterm elections, two of RFK Jr's top aides are expected to leave…...

1+ week, 9+ hour ago  (442+ words) As the pharma industry continues to experiment with AI implantation, certain areas are showing more promise than others. Sandy Tammisetty, VP of Veeva Services Practive Group at Conexus Solutions, spoke with Pharmaceutical Executive about where AI implementation is working for…...

1+ week, 1+ day ago  (453+ words) The letter follows Phase II data that did not sufficiently link biomarker reductions to clinical benefit. Bitopertin was submitted for review under accelerated approval and as part of the Commissioner's National Priority Voucher (CNPV) pilot program.Stock.Adobe.com Disc…...